Medical Devices Startups

Cor.Sync provides a point-of-care diagnostic device for rapid measurement of ultrasensitive troponin in whole blood, enabling hospitals and emergency care teams to quickly diagnose cardiac infarction. The device uses AI-analyzed sensors and delivers quantitative results in 8 minutes without sample preparation.

1 investor

Corbus Pharmaceuticals is a biopharmaceutical company developing therapies for critical stages of clinical development, with a focus on advancing patient-centered progress in drug development. The company is led by a senior leadership team with expertise in pharmaceutical research, regulatory affairs, and clinical development.

1 investor

Corcillum provides a cloud platform for medical image annotation and multi-physics modelling, serving researchers, clinical trials teams, healthcare AI organizations, and medical innovators who need to curate imaging data, perform AI-powered annotation, and conduct functional modelling.

1 investor

Cordex Systems develops SmartCuff, a medical device that repurposes blood pressure cuff technology as a linear sensor to detect early warning signs of heart disease. The device is designed for healthcare professionals and patients at risk of cardiovascular disease.

1 investor

Cordica Medical provides design, development, and manufacturing services for medical device companies, covering product engineering, precision manufacturing, automated assembly, packaging, and supply chain management through FDA-registered and ISO 13485-certified facilities. It supports programs across therapeutic areas including interventional systems, drug delivery, wound care, and personal health, operating 19 facilities in the United States, Mexico, and Singapore.

1 investor

Core Diagnostics offers diagnostic laboratory testing with sample collection services, including routine tests and diagnostic monitoring tests scheduled at defined intervals. The company serves individuals seeking medical diagnostic testing.

1 investor

Corealis Pharma is a contract development and manufacturing organization (CDMO) specializing in oral solid dosage formulation and GMP manufacturing for biotech companies developing complex therapies. The company provides services from early-stage formulation through clinical supply, with integrated R&D and manufacturing infrastructure based in Laval, Canada.

1 investor

CoreBone cultivates corals in a closed lab-based aquarium system to produce natural scaffolds for bone and cartilage tissue engineering, offering dental bone grafts as an alternative to bovine and human grafts. Its products serve dental and orthopedic surgical markets, with a cartilage regeneration platform advancing into clinical trials.

1 investor

Corelinesoft develops aview, a CT-based artificial intelligence software that assists radiologists in image interpretation and enables healthcare institutions to extract broader analytical insights from chest imaging data. The company serves hospitals, screening centers, and research institutions globally, with extensive experience in national lung cancer screening programs.

1 investor

Corentec (㈜코렌텍) develops orthopedic implants, including knee replacement systems such as its EXULT Knee System with CR, PS, CPS, and UCR tibial insert types. The company, which recently received US FDA approval for its UCR-type knee implant, is expanding into the US market.

1 investor

Cori Clinical builds an AI platform that automates the authoring and management of clinical trial documentation, including protocols, consent forms, and regulatory submissions. The platform serves clinical development teams by reducing manual document preparation and ensuring consistency across all trial-related paperwork.

1 investor

Coridea invests in and develops healthcare companies focused on patient-centric solutions. The firm provides capital and support to high-impact medical technology and healthcare ventures.

1 investor

Corify develops ACORYS, a cardiac mapping system for clinicians that performs real-time, beat-to-beat global cardiac mapping to help diagnose cardiac arrhythmias. The system is designed to visualize the entire heart quickly without maneuvering catheters during lengthy operating-room procedures.

1 investor

Corion Biotech develops therapeutic solutions for women's health, with a focus on pregnancy-related disorders such as preeclampsia and fetal growth restriction. The company was founded as an academic spin-off from the University of Turin based on over two decades of translational research in obstetrics and gynecology.

1 investor

Corisma develops a fully implanted transcatheter mechanical circulatory support system for advanced heart failure patients, designed to bridge acute and chronic care with improved quality of life. The device eliminates the driveline and uses wireless, catheter-based technology to replace current standard-of-care treatment options.

1 investor

CORIT Medical develops a Class I single-use, handheld surgical device for inferior turbinate reduction, a procedure used to relieve nasal obstruction and improve breathing. The device is aimed at physicians performing the procedure in-office, targeting the US market where roughly 1 million such procedures occur annually.

1 investor

Cornea Sense develops diagnostic technology for detecting systemic and ocular diseases through ocular hydration assessment. The company targets healthcare providers and patients globally to enable earlier disease diagnosis and preventive healthcare interventions.

1 investor

CoroLogic builds an on-premises software platform for coronary angiography that uses generative AI to reconstruct lower-frame-rate cardiac imaging in real-time, enabling significant dose reduction without compromising diagnostic quality. The solution integrates into existing catheterization lab workflows for hospitals and imaging vendors.

1 investor

Correx develops a medical device system for aortic valve bypass surgery that automates the insertion process, enabling surgeons to perform the procedure on a beating heart without requiring a heart-lung machine. The system is designed for cardiac surgeons performing minimally invasive valve replacement procedures.

1 investor

Corrixr Therapeutics is developing targeted genetic medicine for treatment-resistant cancers, with a focus on advancing its CXR101 therapeutic candidate through clinical development and translational research.

1 investor

Cortical Dynamics develops a brain monitoring device (BARM™) that tracks anesthesia depth in real-time during surgical procedures, particularly for total intravenous anesthesia. The product is designed to improve patient outcomes and reduce the environmental impact of anesthesia administration in operating rooms.

1 investor

CortiCare provides remote continuous EEG monitoring as a virtual EEG department that supports hospital clinical teams rather than replacing them. Its quality assurance program sets standards for technologists, monitoring workflows, and clinical escalation to maintain consistent EEG monitoring across hospitals in the US.

1 investor

Cortirio develops a wearable infrared brain imaging headset for rapid detection of stroke and traumatic brain injury. The device provides portable, on-site diagnosis in under two minutes for clinical use.

1 investor

Cortrium develops a long-term ECG solution that combines wearable hardware, algorithms, and human expertise for recording and reporting to identify arrhythmias and prevent heart disease and stroke. It serves cardiology and healthcare professionals and their patients, operating across multiple countries through partners and distributors.

1 investor